בליאומיצין PFI

Maa: Israel

Kieli: heprea

Lähde: Ministry of Health

Aktiivinen ainesosa:

BLEOMYCIN SULFATE

Saatavilla:

MEGAPHARM LTD

ATC-koodi:

L01DC01

Lääkemuoto:

אבקה להכנת תמיסה לזריקה

Koostumus:

BLEOMYCIN SULFATE 15000 IU/VIAL

Antoreitti:

לתוך קרום הריאה, תוך-עורקי, תוך-ורידי, תת-עורי, תוך-שרירי, לתוך בקע

Prescription tyyppi:

מרשם נדרש

Valmistaja:

BAXTER ONCOLOGY GmbH, GERMANY

Terapeuttinen ryhmä:

BLEOMYCIN

Terapeuttinen alue:

BLEOMYCIN

Käyttöaiheet:

Bleomycin is useful in the management of the following neoplasms: Squamous cell carcinoma affecting the mouth, nasopharynx and paranasal sinuses, larynx, oesaphagus, cervix, vagina, penis and skin. Well differentiated tumors usually respond better than anaplastic ones.Hodgkin's disease and other malignant lymphomas, including mycosis fungoides. Testicular carcinoma (seminoma and no seminoma) .Malignant effusions of serous cavities (intrapleural and intraperitoneal).Secondary indications in which bleomycin has been shown to be of some value include metastatic malignant melanoma, carcinoma of the thyroid lung and bladder. Local treatment of refractory warts. Bleomycin can be used as a single agent, but is generally used in combination with other cytotoxics and/or with radiation therapy.

Valtuutus päivämäärä:

2020-09-30